Equanil and Facial bones fracture - a phase IV clinical study of FDA data

Summary:

Facial bones fracture is reported only by a few people who take Equanil.

The phase IV clinical study analyzes which people take Equanil and have Facial bones fracture. It is created by eHealthMe based on reports of 1,236 people who have side effects while taking Equanil from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 28, 2022

1,236 people reported to have side effects when taking Equanil.
Among them, 4 people (0.32%) have Facial bones fracture.


What is Equanil?

Equanil has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 1,242 Equanil users for its effectiveness, alternative drugs and more.

What is Facial bones fracture?

Facial bones fracture (bone fracture of face) is found to be associated with 1,541 drugs and 872 conditions by eHealthMe.

Number of Equanil and Facial bones fracture reports submitted per year:

Could Equanil cause Facial bones fracture?

Gender of people who have Facial bones fracture when taking Equanil *:

  • female: 75 %
  • male: 25 %

Age of people who have Facial bones fracture when taking Equanil *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Equanil *:

  1. Cymbalta: 3 people, 75.00%
  2. Abilify: 3 people, 75.00%
  3. Cartrol: 2 people, 50.00%
  4. Zolpidem: 1 person, 25.00%
  5. Coumadin: 1 person, 25.00%
  6. Aldactone: 1 person, 25.00%

Common side effects people have besides Facial bones fracture *:

  1. Fall: 4 people, 100.00%
  2. Inappropriate Antidiuretic Hormone Secretion: 3 people, 75.00%
  3. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 3 people, 75.00%
  4. Nosebleed (bleeding from nose): 1 person, 25.00%
  5. Hypokalemia (low potassium): 1 person, 25.00%
  6. Haematemesis (vomiting of blood): 1 person, 25.00%
  7. Cerebral Haemorrhage (bleeding within the brain): 1 person, 25.00%
  8. Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Equanil and have Facial bones fracture?

Check whether Facial bones fracture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Facial bones fracture and when was it recovered:

Expand to all the drugs that have ingredients of meprobamate:

Alternative drugs to, pros and cons of Equanil:

Facial bones fracture treatments and more:

COVID vaccines that are related to Facial bones fracture:

Common drugs associated with Facial bones fracture:

All the drugs that are associated with Facial bones fracture:

Common conditions associated with Facial bones fracture:

All the conditions that are associated with Facial bones fracture:

How the study uses the data?

The study uses data from the FDA. It is based on meprobamate (the active ingredients of Equanil) and Equanil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: